Status:
RECRUITING
High Resolution Gastric Mapping and Gastroduodenal Manometry
Lead Sponsor:
Mayo Clinic
Conditions:
Dyspepsia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Dyspepsia is a common problem attributed to gastric sensorimotor dysfunctions ie, delayed, or less frequently rapid gastric emptying (GE), impaired gastric accommodation, and increased gastric sensati...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Symptoms consistent with functional dyspepsia as defined by the ROME IV criteria for 6 months
- Ability to perform appropriate informed consent
- Exclusion Criteria
- Known cardiac arrhythmia or major ECG abnormalities, i.e. cardiac conduction disturbances (2nd or 3rd degree AV block, prolonged QTc interval (\> 460 msec) or bradycardia (\< 45 beats/minute)
- Conditions precluding safe use of taVNS
- Clinical evidence of significant cardiovascular, respiratory, renal, hepatic, gastrointestinal, hematological, neurological, psychiatric or other disease that may interfere with the objectives of the study and/or pose safety concerns
- Use of opioids
- Vulnerable study population
- Pregnant women
Exclusion
Key Trial Info
Start Date :
July 11 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06941545
Start Date
July 11 2025
End Date
December 31 2026
Last Update
August 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905